Biolife solutions launches new high capacity controlled rate freezer line with first shipment to a leading cell therapy developer

Bothell, wash., april 15, 2021 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (hcrf), with an initial shipment to a leading cell therapy company.
BLFS Ratings Summary
BLFS Quant Ranking